Announcement on Unblinding Results of the Phase III Monotherapy Clinical Trial of the Company's Class 1 New Drug LH-1801 Tablets Combined with Metformin

About this update from Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A

Announcement on Unblinding Results of the Phase III Monotherapy Clinical Trial of the Company's Class 1 New Drug LH-1801 Tablets Combined with Metformin The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A